Impact of Inhomogeneity Corrections on Lung Cancer Treatment Plans
Author Information
Author(s): Danny Schuring, Coen W. Hurkmans
Primary Institution: Catharina-hospital, Department of radiotherapy, Eindhoven, The Netherlands
Hypothesis
How do inhomogeneity corrections affect dose delivery in stereotactic lung cancer treatments?
Conclusion
Inhomogeneity corrections significantly influence the dose delivered to the target and organs at risk in lung cancer treatments, necessitating accurate dose calculations.
Supporting Evidence
- The study found that the dose to the target varied significantly based on the calculation method used.
- Recalculated plans showed that the EPL algorithm consistently overestimated the dose to the PTV.
- The correlation between planned and recalculated lung doses was strong, indicating the importance of accurate calculations.
Takeaway
This study shows that using different methods to calculate radiation doses can change how much radiation actually reaches the tumor, which is very important for treatment.
Methodology
The study involved 26 patients with stage-I NSCLC, comparing treatment plans optimized with different algorithms and recalculating doses using a more accurate method.
Potential Biases
Potential biases may arise from the small sample size and the specific patient characteristics.
Limitations
The study's findings may not be generalizable to larger tumor sizes or different treatment settings.
Participant Demographics
All participants had solitary stage-I non-small cell lung cancer and were medically inoperable.
Statistical Information
P-Value
0.007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website